Literature DB >> 8045709

Long-term photoreceptor transplants in dystrophic and normal mouse retina.

P Gouras1, J Du, H Kjeldbye, S Yamamoto, D J Zack.   

Abstract

PURPOSE: To determine the long-term status of transgenic photoreceptors transplanted to the subretinal space of both rd mutant (receptorless) and normal mouse retina.
METHODS: Microaggregates of neural retina from transgenic mice containing lacZ-labeled photoreceptors were transplanted to the subretinal space of adult rd mutant and normal mice. The transplant site was examined by light and electron microscopy at monthly intervals up to 9 months after transplantation surgery.
RESULTS: Photoreceptors develop and survive well if transplanted with the proper orientation to the retinal pigment epithelium (RPE). The status of the photoreceptors, including outer segments and synaptic terminals, appear normal for at least 9 months after transplantation; they continue to express the lacZ reporter gene. Cones survive as well as rods. Transplants to the normal mouse develop normally, whereas the host photoreceptors displaced from the RPE degenerate. A barrier, formed by Müller cell processes, develops after photoreceptor degeneration in both normal and rd mouse retina and demarcates host from transplant tissue. Areas can be found in which neural processes have penetrated this barrier. There is no evidence of host-graft rejection.
CONCLUSION: Transplanted progenitor photoreceptors develop and survive well for long periods of time in either the rd mutant or normal retina if they are properly positioned. In the former, they reconstitute a photoreceptor layer; in the latter, they replace the host photoreceptor layer, which degenerates after being displaced from the RPE. Areas of potential contact between donor and host neurons exist in these transplants.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8045709

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  23 in total

Review 1.  Prevention and therapy in hereditary retinal degenerations.

Authors:  Dorothea Besch; Eberhart Zrenner
Journal:  Doc Ophthalmol       Date:  2003-01       Impact factor: 2.379

Review 2.  Cell replacement and visual restoration by retinal sheet transplants.

Authors:  Magdalene J Seiler; Robert B Aramant
Journal:  Prog Retin Eye Res       Date:  2012-07-05       Impact factor: 21.198

Review 3.  A tissue-engineered approach towards retinal repair: scaffolds for cell transplantation to the subretinal space.

Authors:  Sara Royce Hynes; Erin B Lavik
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-02-19       Impact factor: 3.117

Review 4.  Gene therapy for inherited retinal degeneration.

Authors:  R R Ali; M B Reichel; D M Hunt; S S Bhattacharya
Journal:  Br J Ophthalmol       Date:  1997-09       Impact factor: 4.638

5.  Pluripotential stem cells as replacement therapy in degenerative diseases of the eye.

Authors:  Colin J Barnstable
Journal:  Ann Transl Med       Date:  2019-07

6.  Tolerance of human fetal retinal pigment epithelium xenografts in monkey retina.

Authors:  L Berglin; P Gouras; Y Sheng; J Lavid; P K Lin; H Cao; H Kjeldbye
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-02       Impact factor: 3.117

7.  Adequate Time Window and Environmental Factors Supporting Retinal Graft Cell Survival in rd Mice.

Authors:  Michiko Mandai; Kohei Homma; Satoshi Okamoto; Chikako Yamada; Akane Nomori; Masayo Takahashi
Journal:  Cell Med       Date:  2012-04-20

8.  Survival and integration of neural retinal transplants in rd mice.

Authors:  Peter Gouras; Teruyo Tanabe
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-04-16       Impact factor: 3.117

9.  A rat model for studying neural stem cell transplantation.

Authors:  Xue-mei Zhou; Jing-bo Sun; Hui-ping Yuan; Dong-lai Wu; Xin-rong Zhou; Da-wei Sun; Hong-yi Li; Zheng-bo Shao; Zhi-ren Zhang
Journal:  Acta Pharmacol Sin       Date:  2009-11       Impact factor: 6.150

10.  Identification of barriers to retinal engraftment of transplanted stem cells.

Authors:  Thomas V Johnson; Natalie D Bull; Keith R Martin
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-22       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.